نتائج البحث 431-440 من 23103 لعملية البحث عن Treatment
... treatment, in order to classify patients into post-consolidation treatment groups. On the second part of this study, patients will receive the remainder of ...
Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients. Scottsdale/Phoenix, Ariz. This project will investigate whether ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Intraoperative Contrast Enhanced Ultrasound for the ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
Carboplatin And Vincristine In Patients With Low-Grade Glioma. Rochester, Minn. This study aims to demonstrate that the efficacy of treatment with selumetinib ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study To Evaluate Regulation Of The ...
... treatment. This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following ...
... treatment (refractory). A Study To Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients For T-cell Directed ...
... treatment (refractory). Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and ...
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.